Jushi Holdings Inc.

JUSH ·Healthcare, Drug Manufacturers - General, United States
Analysis › Moat Score

Moat Score — Jushi Holdings Inc.

Total Moat Score 7 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 2 / 5 Jushi holds limited-license medical cultivation and retail permits in Pennsylvania and Virginia that are scarce and hard to replicate, plus a multi-tier branded product portfolio (Hijinks, The Bank, Tasteology, Seche). These are real but regional and modest relative to national cannabis brand leaders.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 1 / 5 Vertical integration into cultivation and processing in most of its states captures some margin, but Section 280E tax treatment and a heavy debt load (roughly $180-198 million) largely offset any unit-cost advantage versus larger, better-capitalized MSOs.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 1 / 5 Gross margin compressed from 45.9% in FY2024 to 43.4% in FY2025 amid wholesale flower price declines in adult-use markets like Illinois and California, showing limited ability to hold price against oversupply and illicit-market competition.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 0 / 5 Cannabis retail and cultivation exhibit no meaningful network effects; each dispensary and grow facility operates independently with no cross-customer or cross-side value creation.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 1 / 5 Consumer switching costs are low in a commoditized retail category; however, medical patients in states like Pennsylvania and Virginia show some loyalty tied to specific dispensary relationships and product familiarity.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 2 / 5 Limited-license medical markets such as Pennsylvania and Virginia cap the number of competing cultivators/dispensaries, giving incumbents like Jushi a degree of protected, efficient-scale positioning that new entrants cannot easily replicate absent a new license round.